National Health Institute of Nouvelle Alexandrie
| National Health Institute | |
 | |
| Formed | 1686 AN |
|---|---|
| Preceding agency |
|
| Type | Federal research agency |
| Jurisdiction |
 Nouvelle Alexandrie |
| Headquarters | Vida Science Park, Cárdenas |
| Employees | 18,400 (1750 AN) |
| Annual budget | NAX€65.2 billion (1750 AN) |
| Secretary of Social Security and National Solidarity | Elias Wilson-Clarke |
| Director General | Felipe Loubriel (1749 AN) |
| Parent agency | Department of Social Security and National Solidarity |
| Child agencies |
|
The National Health Institute (Alexandrian: Institut National de Santé; Martino: Instituto Nacional de Salud; Wechua: Kawsaysuchasqa Taqay Tantanakuna Qali Kay), commonly known by its acronym INS, is the primary agency of Nouvelle Alexandrie responsible for biomedical and public health research. The institute operates under the Department of Social Security and National Solidarity and oversees 15 centers of expertise covering various medical specialties. It is considered one of the foremost organizations for life sciences and medicine on Micras.
The INS conducts scientific research through its internal Research Program and provides funding to external researchers through the Allied Biomedical Program. As of 1750 AN, the INS employs over 2,600 principal investigators and more than 7,200 postdoctoral fellows engaged in basic, translational, and clinical research. External funding through the Allied Biomedical Program provides over 19% of all annual biomedical research funding in Nouvelle Alexandrie, exceeding NAX€12.4 billion. Basic research conducted by the INS contributes to over 75% of all new drug approvals by the National Food and Drug Agency.
History
The INS was founded by the Department of Social Security and National Solidarity in 1686 AN to consolidate the disparate biomedical research efforts across the newly formed federation. At its founding, the institute absorbed five pre-existing organizations: the Scientific Review Board, Centre for Healthcare Ethics, Federal Center for Cancer Research, Office of Disease Prevention, and Office of Biotechnology.
Initially headquartered in Parap, the capital of the Wechua Nation, the INS relocated to its current headquarters at Vida Science Park in Cárdenas in 1690 AN. The move coincided with the establishment of Vida Science Park as part of the Cárdenas Plan, which sought to create a national hub for biomedical research. Over the following decades, the institute opened 14 additional science centers dedicated to various fields including neurology, infectious disease, genetics, and bioengineering. It also established eight associated operating groups to support medical science coordination.
The INS has been instrumental in numerous medical advances since its founding. Major achievements include the discovery of novel drug compounds, research into epidemics such as AIDS and the White Plague, and innovation in medical technology. Beginning in 1707 AN, the institute expanded its focus to include research on the human genome, advanced proteomic sequencing, and addiction treatment. The Federal Center for the Human Genome, established that year, collaborated with the National Centre for Biotechnology and Bioinformatics to complete the first national genome databank in 1720 AN.
In 1738 AN, the Frontera Program appropriated NAX€1.8 billion for expansion and upgrades to INS-affiliated research centers, including the National Centre for Biotechnology and Bioinformatics and the Research Institute for Genomics and Proteomics. The institute has also played a role in responding to public health emergencies, including the 1734 New Alexandrian drug shortages and the 1746 AN Libertad Fever outbreak, during which the INS mobilized epidemiologists, vector control specialists, and emergency medical personnel.
Since the mid-1740s, the INS has been involved in the development of Alexandrium-based medical technologies through collaboration with the civilian research programs of the Force 1752 initiative. In 1742 AN, researchers affiliated with the University of Cárdenas and the INS achieved a breakthrough in CRISPR-Alexandrium gene editing technology, achieving a 78% recovery rate in patients with Cardona's Syndrome, a rare neurological disorder.
Organization
The INS is overseen by the General Directorate, the central administrative office of the organization. The Directorate sets policy for the institute and oversees the programs and activities of all INS components, including its 15 specialized centers of expertise. Principal centers include the Federal Center for Cancer Research (established 1685 AN), Federal Center for Cardiovascular Disease (established 1689 AN), Federal Center for Immunology and Infectious Diseases (established 1694 AN), Federal Center for the Human Genome (established 1707 AN), and Federal Center for Bioengineering and Biomedical Imaging (established 1707 AN).
The General Directorate maintains six Mission Offices that coordinate research efforts across all divisions in specific areas of public health concern:
- Mission Office for Behavioral and Social Sciences
- Mission Office for Dietary Needs
- Mission Office for Wechua and Wakara Health Research
- Mission Office for Sexual and Gender Minority Research
- Mission Office for STDs
- Mission Office for Women's Health
The Office of Planning, Program Coordination, and Strategy oversees the planning and execution of biomedical research under the INS institutes and ensures research integrity within the organization. The Office of Finances manages funding for both internal and external programs.
The INS maintains its headquarters and seven research centers at Vida Science Park in Cárdenas, with additional facilities in Lausanne and Punta Santiago.
Research
In 1750 AN, the INS dedicated approximately 20% of its total funding to research conducted within its own facilities and directed more than 80% to research grants for external researchers. Of this external funding, more than 8% supports small businesses and an additional 4% supports minority-owned businesses. During the 1749 AN fiscal year, more than 92,000 grants were awarded to over 550,000 researchers at over 2,700 institutions across Nouvelle Alexandrie.
Research expenditure in 1750 AN included NAX€32.5 billion for clinical research, NAX€5.6 billion for genetics research, NAX€7.8 billion for prevention research, NAX€4.8 billion for cancer, and NAX€7.9 billion for biotechnology.
Library of Medicine
The Federal Library of Medicine, established in 1692 AN, provides principal investigators and the general public with free access to research papers published by the INS and grantees of its external programs. The library maintains an open access policy requiring that all electronic versions of published research be made publicly available no later than 12 months after publication. It is the largest national repository for biomedical research in Nouvelle Alexandrie.
National Genetic Databank
The Federal Center for the Human Genome hosts the National Genetic Databank, a repository of information produced by studies investigating the human genome. The databank stores genotypes, molecular assay data, analyses, and supporting documents. Summary-level data is available to the general public, while individual-level data is accessible only to qualified researchers. The databank was completed in collaboration with the National Centre for Biotechnology and Bioinformatics in 1720 AN.
INS Toolbox
The Federal Center for General Medical Sciences has developed the INS Toolbox since 1708 AN, a standardized evaluation methodology designed to enhance data collection in large clinical studies. The toolbox enables INS institutes and external grantees to perform standardized clinical trials, accelerating drug discovery, regulatory approval, and commercialization of medical treatments.
Interagency Program
The National Interagency Program is a task force established in 1705 AN to integrate biomedical research and innovation among the various INS institutes. The program aims to prevent redundancy, improve collaboration, and accelerate the publication and commercialization of medical research. It coordinates with other federal research institutions including the Institute for Advanced Biomedical Research, the National Centre for Biotechnology and Bioinformatics, and the Institute for Environmental Health Sciences and Toxicology.
